114 related articles for article (PubMed ID: 19546433)
1. Re: Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
Vigneri R; Frasca F; Sciacca L; Vigneri P; Frittitta L
J Natl Cancer Inst; 2009 Jul; 101(14):1030-1; author reply 1031-2. PubMed ID: 19546433
[No Abstract] [Full Text] [Related]
2. Insulin-like growth factor-binding protein-3, breast cancer risk, and different serum assays.
Renehan A
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1844. PubMed ID: 16030128
[No Abstract] [Full Text] [Related]
3. Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis.
Pasanisi P; Venturelli E; Morelli D; Fontana L; Secreto G; Berrino F
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1719-22. PubMed ID: 18628423
[TBL] [Abstract][Full Text] [Related]
4. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women.
Gunter MJ; Hoover DR; Yu H; Wassertheil-Smoller S; Rohan TE; Manson JE; Li J; Ho GY; Xue X; Anderson GL; Kaplan RC; Harris TG; Howard BV; Wylie-Rosett J; Burk RD; Strickler HD
J Natl Cancer Inst; 2009 Jan; 101(1):48-60. PubMed ID: 19116382
[TBL] [Abstract][Full Text] [Related]
5. No effect of exercise on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 in postmenopausal women: a 12-month randomized clinical trial.
McTiernan A; Sorensen B; Yasui Y; Tworoger SS; Ulrich CM; Irwin ML; Rudolph RE; Stanczyk FZ; Schwartz RS; Potter JD
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1020-1. PubMed ID: 15824183
[No Abstract] [Full Text] [Related]
6. The potential clinical applications of insulin-like growth factor-1 ligand in human breast cancer.
Chong YM; Subramanian A; Sharma AK; Mokbel K
Anticancer Res; 2007; 27(3B):1617-24. PubMed ID: 17595785
[TBL] [Abstract][Full Text] [Related]
7. Physical activity and postmenopausal breast cancer: proposed biologic mechanisms and areas for future research.
Neilson HK; Friedenreich CM; Brockton NT; Millikan RC
Cancer Epidemiol Biomarkers Prev; 2009 Jan; 18(1):11-27. PubMed ID: 19124476
[TBL] [Abstract][Full Text] [Related]
8. Homing in on mechanisms linking breast density to breast cancer risk.
Brower V
J Natl Cancer Inst; 2010 Jun; 102(12):843-5. PubMed ID: 20530764
[No Abstract] [Full Text] [Related]
9. Correspondence re: C. R. Jonas et al., Dietary glycemic index, glycemic load, and risk of incident breast cancer in postmenopausal women. Cancer Epidemiol. Biomark. Prev., 12: 573-577, 2003.
Folsom AR; Demissie Z; Harnack L
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1547. PubMed ID: 14693753
[No Abstract] [Full Text] [Related]
10. Differential effects of various progestogens on metabolic risk factors for breast cancer.
Campagnoli C; Abbà C; Ambroggio S; Lotano MR; Peris C
Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():22-31. PubMed ID: 17943536
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer: the obesity connection.
Stoll BA
Br J Cancer; 1994 May; 69(5):799-801. PubMed ID: 8180007
[No Abstract] [Full Text] [Related]
12. Obesity and cancer treatment: weighing the evidence.
Griggs JJ; Sabel MS
J Clin Oncol; 2008 Sep; 26(25):4060-2. PubMed ID: 18757320
[No Abstract] [Full Text] [Related]
13. Insulin and IGF-I as determinants of low "Western" cancer rates in the rural third world.
McCarty MF
Int J Epidemiol; 2004 Aug; 33(4):908-10. PubMed ID: 15256521
[No Abstract] [Full Text] [Related]
14. Insulin breast cancer connection: confirmatory data set the stage for better care.
DeCensi A; Gennari A
J Clin Oncol; 2011 Jan; 29(1):7-10. PubMed ID: 21115871
[No Abstract] [Full Text] [Related]
15. Correspondence re: Chokkalingam A. et al., Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol. Biomark. Prev., 10: 421-427, 2001.
Muti P; Gaddi P; Quattrin T
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):323. PubMed ID: 11895887
[No Abstract] [Full Text] [Related]
16. The expression and function of IGFBP-3 in normal and malignant breast tissue.
McCarthy K; Laban C; McVittie CJ; Ogunkolade W; Khalaf S; Bustin S; Carpenter R; Jenkins PJ
Anticancer Res; 2009 Oct; 29(10):3785-90. PubMed ID: 19846909
[TBL] [Abstract][Full Text] [Related]
17. Krüppel-like factor 5 promotes breast cell proliferation partially through upregulating the transcription of fibroblast growth factor binding protein 1.
Zheng HQ; Zhou Z; Huang J; Chaudhury L; Dong JT; Chen C
Oncogene; 2009 Oct; 28(42):3702-13. PubMed ID: 19668233
[TBL] [Abstract][Full Text] [Related]
18. Insulinemia and the risk of breast cancer and its relapse.
Formica V; Tesauro M; Cardillo C; Roselli M
Diabetes Obes Metab; 2012 Dec; 14(12):1073-80. PubMed ID: 22537210
[TBL] [Abstract][Full Text] [Related]
19. Regarding the article 'Does the negative correlation found in breast cancer patients between plasma melatonin and insulin-like growth factor-1 concentrations imply the existence of an additional mechanism of oncostatic melatonin influence involved in defense?' by Kajdaniuk et al.
Iizuka N
Med Sci Monit; 2002 Oct; 8(10):LE42-3. PubMed ID: 12434788
[No Abstract] [Full Text] [Related]
20. Re: C-reactive protein and risk of breast cancer.
Zeleniuch-Jacquotte A; Gu Y; Bruning PF; Bonfrer JM; Koenig KL; Arslan AA; Toniolo P; Shore RE
J Natl Cancer Inst; 2008 Mar; 100(6):443-4; author reply 444-5. PubMed ID: 18334713
[No Abstract] [Full Text] [Related]
[Next] [New Search]
